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Abstract
Background: Staphylococcus aureus (S. aureus) infections range in severity due to expression of certain virulence
factors encoded on mobile genetic elements (MGE). As such, characterization of these MGE, as well as single
nucleotide polymorphisms, is of high clinical and microbiological importance. To understand the evolution of these
dangerous pathogens, it is paramount to define reference strains that may predate MGE acquisition. One such
candidate is S. aureus Tager 104, a previously uncharacterized strain isolated from a patient with impetigo in 1947.
Results: We show here that S. aureus Tager 104 can survive in the bloodstream and infect naïve organs. We also
demonstrate a procedure to construct and validate the assembly of S. aureus genomes, using Tager 104 as a proof-
of-concept. In so doing, we bridged confounding gap regions that limited our initial attempts to close this 2.82 Mb
genome, through integration of data from Illumina Nextera paired-end, PacBio RS, and Lucigen NxSeq mate-pair
libraries. Furthermore, we provide independent confirmation of our segmental arrangement of the Tager 104 genome by
the sole use of Lucigen NxSeq libraries filled by paired-end MiSeq reads and alignment with SPAdes software. Genomic
analysis of Tager 104 revealed limited MGE, and a νSaβ island configuration that is reminiscent of other hospital acquired
S. aureus genomes.
Conclusions: Tager 104 represents an early-branching ancestor of certain hospital-acquired strains. Combined with its
earlier isolation date and limited content of MGE, Tager 104 can serve as a viable reference for future comparative
genome studies.
Background
The prevalence of methicillin-resistance in Staphylococcus
aureus (S. aureus) is a global threat as noted by the
Centers for Disease Control and Prevention 2013 Threat
Report [1]. S. aureus strains are heterogeneous, and there-
fore can cause a wide range of localized infections, such as
impetigo and cellulitis, to more serious systemic infec-
tions, such as bacterial endocarditis and sepsis. In particu-
lar, S. aureus is the leading cause of bacterial endocarditis,
a disease with mortality rates as high as 25–47 %, even in
the presence of antibiotic therapy [2]. This wide range of
infections, as well as the growing number of pathogens
with diverse antibiotic resistance profiles, is due to the
acquisition of mobile genetic elements (MGEs) that grant
heterogeneity to S. aureus strains. The best described of
these MGEs is the Staphylococcal Cassette Chromosome
mec (SCCmec) operon, which encodes the mecA gene and
confers methicillin resistance [3]. However, many other
MGEs can confer adaptive advantages during infection,
such as enterotoxins [4], leukocidins (most prominently
the Panton-Valentine leukocidin, pvl, encoded by the lukF-
PV and lukS-PV genes) [3, 4], staphylokinase (sak) [5], and
the toxic shock syndrome toxin-1 [6]. Therefore, there is
an urgent need to better understand the evolutionary adap-
tations commonly associated with acquisition of MGE that
contribute to (i) the prevalence of nosocomial infections,
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(ii) the rapid spread of community-acquired strains, (iii)
development and expansion of novel resistance mecha-
nisms, and (iv) natural host selection and propagation
pathways.
To juxtapose recent next-generation sequencing efforts
with pathogenic potential, it is necessary to have several
well-characterized reference strains to use as landmarks to
interpret MGE findings. This is currently lacking in the
field, as the most popular strains (i.e. methicillin-sensitive
S. aureus (MSSA) Newman [7], methicillin-resistant S.
aureus (MRSA) USA300 [8], and vancomycin-resistant S.
aureus (VRSA) Mu50 [4, 9]) are complicated by horizontal
gene transfer of MGE and inclusion of various prophages
that were gained to most likely provide some sort of
survival advantage. As such, it is prudent to define strains
with a balance between limited MGE presence and potent
pathogenic potential.
Here we describe one such strain, which we term S.
aureus Tager 104. Tager 104 was originally isolated at
the New Haven Hospital (New Haven, Connecticut) by
Morris Tager et al. in 1947 from a patient with a cutane-
ous infection caused by a hemolytic bacteria [10, 11]. As
a comparison, the first strain of methicillin-resistant S.
aureus was isolated in 1961 [3]. Morris Tager and co-
workers subsequently demonstrated that S. aureus Tager
104 induced clotting through expression of secreted
factors [12], developed staphylocoagulase purification
protocols [13], and initiated preliminary characterization
of staphylocoagulase function in contrast to normal
physiologic clotting [14, 15]. Currently, staphylocoagu-
lase from S. aureus Tager 104 is arguably the most well
characterized prothrombin activator studied to date, as
it was the original source used to solve the staphylocoa-
gulase (1–325) fragment crystal structure in complex
with both thrombin and its immediate precursor, pre-
thrombin 2 [16]. This recombinant N-terminal fragment
of staphylocoagulase from Tager 104 binds with high affin-
ity (KD 17–72 pM) to the human prothrombin zymogen
[17], which was also used to characterize fibrinogen recog-
nition by the prothrombin-staphylocoagulase complex and
to determine that two prothrombin-staphylocoagulase
complexes bind to a single substrate fibrinogen molecule
to mediate cleavage [18]. With the wealth of biochemical
insight that has been generated from Tager 104 virulence
factors, the genomic characterization has merit from both
clinical and evolutionary perspectives.
Methods
Ethics statement
For this study, C57BL/6 mice were purchased from The
Jackson Laboratories (Bar Harbor, ME). Mice were housed
at Auburn University College of Veterinary Medicine with
ad libitum access to alfalfa-free chow and water. All
procedures were designed in accordance with the Guide
for the Care and Use of Laboratory Animals of the
National Institutes of Health and approved by the
Institutional Animal Care and Use Committee of
Auburn University for this sepsis model under protocol
2014–2427. S. aureus strain Tager 104 was obtained as
a depersonalized human isolate from an outside source
and therefore no ethics approval was required for its
use in this study.
Mouse model of systemic infection
For this experiment, 12 female C57BL/6 were anesthe-
tized with 1-3 % isoflurane mixed with medical grade
oxygen using a vaporizer. S. aureus Tager 104 was grown
overnight at 37 °C in 50 mL of brain-heart infusion
(BHI) broth in a 125 mL Erlenmeyer flask. Cells were
twice washed with 40 mL of filter-sterilized phosphate
buffered saline (PBS) supplemented with 10 % glycerol.
Cells were pelleted by centrifugation at 10,000 × g for
10 min and the cell pellet was re-suspended in a final
volume of 10 mL of PBS with 10 % glycerol. A sample
from this inoculum stock was diluted 1:100 in PBS with
10 % glycerol in a cuvette for determination of cell dens-
ity by measuring the absorbance at an optical density
(O.D.) at 600 nm using a Beckman Coulter DU800 spec-
trophotometer. These freshly prepared inoculums were
injected into these 12 female C57BL/6 mice by tail-vein
at a dose of 5 × 108 colony forming units (CFU). After
24 h, the animals were euthanized.
Histology
Organs were harvested, stored in 4 % paraformaldehyde,
and embedded in optimal cutting temperature (OCT)
medium by immersing in 4-methylbutane in a metal
canister within a dry-ice bath. Slices (10 microns in
width) were made using a Thermo HM550 Cryostat set
at −19 °C, and fixed to poly-L-lysine coated slides. Slides
were then stained using standard Gram and hematoxylin
and eosin (H&E) staining protocols. Slides were viewed
at 100 or 400 times total magnification on a Zeiss
Axioskop 40 microscope, and images were taken using
a Nikon DS-Fi1 camera head and DS-L3 control unit.
Lucigen NxSeq library construction
Genomic DNAs were prepared by E.Z.N.A. Bacterial
D.N.A. kit (Omega Bio-tek, Norcross, GA). All genomic
DNA preparations were evaluated for approximate size
and integrity by Pulsed Field Gel Electrophoresis with a
BioRad CHEF-DR III instrument. Fragment Libraries
were constructed with a NxSeq DNA Sample Prep Kit
(Lucigen). Briefly, genomic DNAs were sheared to ap-
proximately 500 to 700 bp with a Covaris instrument
and fragment size was confirmed by agarose gel electro-
phoresis. Five hundred ng sheared DNA was mixed with
2X buffer and a cocktail of end repair and tailing
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enzymes and then incubated at 25 °C for 20 min and then
72 °C for 25 min. Illumina sequencing adaptors and ligase
were then added and the tubes were incubated at 25 °C
for 30 min prior to size selection with Agencourt AMPure
XP beads (Beckman Coulter). Fragment libraries were
then quantified with a 2100 Bioanalyzer (Agilent Tech-
nologies), sequenced on a MiSeq Sequencer (Illumina)
and 2 × 250 paired end reads were exported for analysis.
Mate pair libraries
Insert preparation, size selection and library construc-
tion followed the NxSeq® 8 kb Long Mate Pair Library
Kit. Briefly, 8 kb mate pair library insert was sheared to
approximately 10 kb with either a Megaruptor (Diagenode
Inc., Denville, NJ) or a g-TUBE (Covaris, Woburn, MA).
Sheared DNA was bead-cleaned and then size-selected
with Agencourt AMPure XP beads. After size selection
and quantification with a Qubit 2.0 Fluorometer (Thermo-
Fisher), 400 ng of insert was ligated to a coupler at a con-
centration of 1 ng/μL for 16 h at 16 °C. Unligated DNA
was removed by digestion with exonucleases and the
circularized DNA was purified with Agencourt AMPure
XP beads. Purified DNA was then digested with endo-
nucleases (ThermoFisher) to remove DNA between the
two ditags, and the ditag-ligated coupler was purified
by biotin capture with MyOne C1 streptavidin mag-
netic beads (ThermoFisher). The purified ditag-ligated
coupler was then G-tailed and ligated to a C-Tailed
Junction Code adaptor. After bead cleaning to remove
unligated adaptor, the Junction Code adapted DNA was
re-circularized at low concentration, cleaned with
Agencourt AMPure XP beads and then amplified with
Accura HF Hot Start Master Mix (Lucigen) and
indexed primers.
Construction of 20 kb mate pair libraries followed the
NxSeq® 20 kb Long Mate Pair Library Kit protocol. Briefly,
15 μg of high molecular weight genomic DNA was
sheared to 20 kb with a g-TUBE at 4500 rpm, end
repaired, A-tailed and ligated to adaptors prior to precipi-
tation and resuspension in 10 mM Tris. Adapted insert
was gel-isolated either with a BluePippin instrument (Sage
Science) or by separation on a 0.3 % SeaKem Gold agarose
(Lonza) followed by electroelution with an EluTrap device
(Whatman). Gel-isolated insert was then quantified by
Qubit and 1 μg of insert was ligated to a coupler at a con-
centration of 1.25 ng/μL for 16 h at 4 °C. Unligated DNA
was removed by digestion with exonucleases and the cir-
cularized DNA was purified by alcohol precipitation. The
20 kb protocol continues with endonuclease digestion as
described above for the 8 kb mate pair protocol. Mate pair
libraries were quantified with a 2100 Bioanalyzer, se-
quenced on a MiSeq Sequencer (Illumina) and 2 × 250
paired end reads were exported for subsequent filtering
and trimming.
True mate pairs were filtered by analysis and trim-
ming of Chimera Code coupler sequences using the
Chimera-Clean5 Python script (Lucigen); junctions
between left and right di-tags were identified by pres-
ence of the Junction Code linker and di-tags extracted
using the JunctionSplit9 Python script (Lucigen).
Tager 104 genome construction
Genomic DNA was extracted from Tager 104 using
E.Z.N.A. Bacterial D.N.A. kit (Omega Bio-tek, Norcross,
GA) and constructed into a bar-coded library using
the Nextera DNA sample preparation kit (Illumina,
San Diego, CA). Sequencing was performed using an
Illumina MiSeq sequencer for 2 × 150 paired end
reads and trimmed sequence reads were assembled
de novo using CLC Bio v. 4.6.1, as described previ-
ously [19]. To scaffold these contigs, a sub-library of
Tager 104 was constructed for PacBio SMRT sequen-
cing. Two sequencing reactions were performed, and
CLC bio contigs were scaffolded using Celera As-
sembler pipeline on the SMRT analysis 1.3 suite
[19].
To overcome the innate difficulty in genome closure
in this initial construction, PacBio reads were instead as-
sembled de novo using SMRT Analysis v. 2.0 Hierarch-
ical Genome Assembly Process (HGAP) algorithm [20],
which produced 8 contigs. To close the genome, two
Lucigen NxSeq 20 kb mate-pair libraries were con-
structed and sequenced on an Illumina HiSeq system.
PacBio HGAP scaffolds and Lucigen NxSeq paired-end
reads from the mate-pair library were provided to
SSAKE-based scaffolding of Pre-Assembled Contigs after
Extension (SSPACE) [21] for de novo assembly to create
the closed draft genome. Gap regions in this genome
were closed using a combination of the GapFiller algo-
rithm (as part of the SSPACE suite) and Basic Local
Alignment Search Tool (BLAST) search against the ini-
tial CLC contigs for those which bridge gap regions.
This complete, circular genome was submitted to the
Rapid Annotation using Subsystem Technology (RAST)
server [22–24].
To confirm the construction of Tager 104 using an in-
dependent method, new libraries were constructed using
the Nextera DNA kit and sequenced using Illumina
MiSeq 2 × 250 reactions. These results were combined
using the St. Petersburg genome assembler (SPAdes)
algorithm [25] for genome closure.
Construction validation and analysis
To test the contribution of repeats to the shortcomings
in genome assembly, long repeats (>500 bp) were identi-
fied using Nucmer mapping of the Tager 104 genome to
itself [26] and selecting for regions with unique locations
and proper size. In addition, interspersed repeats and
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RNA sequences were identified using the RepeatMasker
algorithm (www.repeatmasker.org). The coordinates of
unique repeats were recorded and provided to Circos
version 0.64 (www.circos.ca).
To determine the contribution of Illumina MiSeq con-
tigs (constructed using CLC), PacBio RS sequencing reads,
and scaffolds constructed from the combination of the
two, results from each assembly were mapped to the Tager
104 genome using Nucmer. The locations of each unique
mapping were provided to Circos for visualization.
MLST analysis
To compare the lineage of Tager 104 to other clinical S.
aureus strains, we employed multi-locus sequence typing
(MLST). FASTA-formatted genomic sequences of com-
pleted S. aureus genomes were obtained from the RefSeq
database on GenBank and uploaded to CLC Workbench.
The identity of the seven housekeeping genes (carbamate
kinase, arc; shikimate dehydrogenase, aro; glycerol kinase,
glp; guanylate kinase, gmk; phosphate acetyltransferase,
pta; triosephosphate isomerase, tpi; acetyl coenzyme A
acetyltransferase, yqi) were determined in silico using the
MLST module (http://www.clcbio.com/clc-plugin/mlst/).
The sequence type of Tager 104 was determined previ-
ously to be ST49, as outlined elsewhere [19].
Proteomic analysis of Tager 104 genome
To perform whole-genome comparisons of Tager 104 to
reference S. aureus strains, a CMG-Biotools virtual
machine was graciously provided by Dr. David Ussery
[27]. One reference genome was selected from each ST
group represented in MLST analysis. Each genome se-
quence was downloaded from GenBank using the getgbk
(i.e., content) function, and converted into FASTA files
using saco_convert. These files were then submitted to
the prodigalrunner algorithm to process the open reading
frames and create a protein FASTA file. The makebmdest
and blastmatrix algorithms were then utilized to construct
BLAST matrices using one representative from each ST.
Whole-genome phylogenetic analysis
The Tager 104 genome and the GenBank reference se-
quence genomes were obtained from RAST and GenBank,
respectively. Genomes were submitted to alignment by
the Mauve algorithm using default parameters [28].
Orthologs were extracted from the resulting .xmfa file
using stripSubsetLCBs (http://darlinglab.org/mauve/snap-
shots/2015/2015-01-09/linux-x64/) with the minimum lo-
cally colinear blocks length set to 500 bp and the number
of genomes set to 75. The result was then converted to
FASTA format using the xmfa2fasta.pl script, and the
FASTA-formatted alignment was then converted to phylip
format using the fasta2phylip.pl script (both parts of the
BioPerl package) (www.bioperl.org). To construct the
phylogenetic tree, a maximum-likelihood tree was con-
structed using the RAxML program on the Cyberinfras-
tructure for Phylogenetic Research (CIPRES) Science
Gateway using default settings (www.phylo.org/portal2/
home.action), and the image was constructed using Fig-
Tree (tree.bio.ed.ac.uk/software/figtree).
MGE-encoded gene determinations
The list of MGE-encoded predicted virulence factors
was determined based on previous studies by our lab
and others, and reviewed elsewhere [3]. The RAST ser-
ver was first searched for the presence of each protein-
encoding gene (PEG). In cases where no annotated PEG
was detected, the UniProt server (www.uniprot.org) was
used to obtain DNA sequences for BLAST analysis. The
genetic location of these elements was recorded and
provided to Circos for graphic representation.
To compare genomes of the Tager clade, we utilized
the BLAST Ring Image Generator (BRIG) algorithm
(http://brig.sourceforge.net/) with default parameters [29].
Genomic islands were determined using the Island-
Viewer 3 algorithm, available online at http://www.patho
genomics.sfu.ca/islandviewer. Islands were identified based
on their genetic content, as reported by the IslandViewer
output and BLAST analysis.
For the νSaβ genomic island, genomic profiles were
constructed using the RAST server. After determination
of the profile, open reading frames were recolored based
on their family or function.
Antibiotic susceptibility testing
S. aureus Tager 104 was streaked for a lawn on trypti-
case soy agar (TSA) plates containing 5 % sheep blood
(BD Biosciences). E-test strips for erythromycin (ER),
linezolid (LZ), oxacillin (OX), and vancomycin (VA)
(bioMérieux, Inc.) were then placed onto the surface of
the agar using sterile forceps. All resistance tests were
performed under conditions that were naïve for the S.
aureus Tager 104 strain to not complicate interpretation
by inducing vancomycin-resistance. Bacteria were incu-
bated at 37 °C for 17 h and plates were imaged using an
IVIS Lumina XR system. In addition, overnight cultures
of S. aureus Tager 104 were added at a 1:200 ratio to
wells containing BHI broth and serial diluted concentra-
tions of vancomycin. The 96-well plate was incubated
for 17 h in an incubator and the O.D.600nm was deter-
mined using a Thermo Scientific VarioSkan plate reader.
Data was subsequently plotted using Graph Pad Prism
v4.03.
Results
S. aureus Tager 104 abscess formation in naïve tissue
Histology indicates that S. aureus Tager 104 is able to
colonize all tissue with variable coverage at this time
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point as indicated by Gram staining (Fig. 1). Bacteria
were detected in the alveoli cells of the lung (not
shown), the white pulp of the spleen, and glomerulus of
the kidney. This supports the previous hypothesis that
Tager 104 is capable of systemic spread. Given our previ-
ous studies [30, 31], we now know that Tager 104 can
cause both endocarditis and establish abscesses in naïve
tissue. We sought to better characterize this Tager 104
at a genomic level to consider all potential virulence de-
terminants prior to comparative virulence studies with
other S. aureus strains.
Construction of S. aureus Tager 104 genome
To close the S. aureus Tager 104 genome, three different
sequencing technologies were used: Illumina Miseq 2 ×
150 bp reactions, PacBio RS 90-min movies, and Lucigen
NxSeq 20 kb mate-pair libraries. In all approaches, scaffolds
were constructed using one of either Illumina MiSeq or
PacBio RS, or a combination of the two (hybrid assembly).
We first sought to close the hybrid assembly scaffolds
previously produced for Tager 104 [19]. Therefore, these
scaffolds were submitted to the SSPACE algorithm with
the Lucigen NxSeq mate pair sequences. This approach
successfully closed the genome, producing the 2.8 Mb S.
aureus genome. However, this approach left six large
gaps in the assembly, which would have required signifi-
cant manual closure.
Therefore, we instead tested the ability of PacBio RS
sequencing reactions in combination with NxSeq mate-
pair libraries. Scaffolds were produced using the Hier-
archical Genome Assembly Process (HGAP) assembly
algorithm on the PacBio SMRT Analysis suite (v 2.0)
[20]. This algorithm produced 8 scaffolds from raw
sequencing data, with an N50 value of 1,028,373 bp.
These scaffolds were then closed using de-duplicated
NxSeq reads using SSPACE. When possible, small gaps
were filled by aligning CLC-constructed Illumina contigs
to the genome using a BLAST search. The result was a
closed 2.82 Mbp genome (Fig. 2a).
To independently confirm our scaffolding of the puta-
tive 2.82 Mbp genome, Illumina MiSeq 2 × 250 libraries
were constructed and sequenced using Illumina 2 × 250
sequencing reactions, and the resulting contigs were
scaffolded using Lucigen NxSeq reactions. The resulting
closed genome was identical to that produced by the hy-
brid HGAP-SSPACE assembly pipeline (Fig. 2b).
Repeat regions created difficulty in automated closure
To determine the shortcomings of individual methods
on the closing of the Tager 104 genome, as a model for
future S. aureus genome assembly, each contig or scaf-
fold was mapped to the final genome using Nucmer and
visualized using Circos (Fig. 3). In addition, repeats were
determined by mapping the Tager genome to itself and
selecting for matches with unique locations and a size >
500 bp. Interspersed repeats and RNA sequences were
determined using the RepeatMasker algorithm. Based
on the analysis, Illumina MiSeq 2 × 150 reads did not
properly bridge areas of the genome that were rich in
repeats. More specifically, repeats > 500 bp (Fig. 3, Re-
gion 1) and RNA repeats (Fig. 3, Region 2) caused
the greatest issues in construction, as visualized. In
addition, PacBio RS coverage was low across these
areas. Therefore, information provided by the Lucigen
NxSeq sequencing reactions was essential for the
proper untangling and assignment of these genomic
regions.
Proteomic analysis of S. aureus reference sequences
Delineation of the S. aureus strains is typically achieved
using MLST analysis. Briefly, the analysis utilizes se-
quence heterogeneity among seven housekeeping genes
to provide a higher resolution phylogenetic analysis.
Fig. 1 S. aureus Tager 104 Bacteremia Leading to Multi-organ Septic
Foci. a Gram staining of C57BL/6 kidney 8 days after injection of
5 × 108 CFU S. aureus Tager 104. b Higher magnification (400× total)
of the indicated by the box in panel a. Arrows indicate the protective
fibrin layer that allows the bacteria to thrive in the glomerulus (GM)
without the threat of clearance by phagocytic immune cells (see area
immediately surrounding infected GM shown in Panel a). c Adjacent
section of the same kidney stained with Hematoxylin and Eosin (H&E);
please note the GM is at a slightly earlier stage of the disease. Kidney
architecture including the collecting ducts (CD), the distal tubule (DT),
and blood cells (red). d Gram staining shows bacteria (purple) in all
organs examined; splenic abscesses also show thickening of the
marginal zone and increased fibrin deposition (arrows). e Adjacent
section stained for H&E showing the splenic architecture including the
white pulp (WP) region, marginal zone (MZ) and red pulp (RP) region
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Reference genomes were obtained from the GenBank
RefSeq database (Additional file 1: Table S1). MLST and
spa typing of S. aureus Tager 104 previously revealed it
to be ST49, the predicted founder of clonal complex 49
(CC49) [19]. CC49 was also shown to contain ST138,
ST1693, ST1937, and ST2273 based on eBurst analysis
(data not shown) [32].
To determine the similarities of protein content in
completed sequences of S. aureus, each genome was
called for open reading frames using the prodigalrunner
algorithm and compared using the blastmatrix algorithm
on CMG-Biotools version 2.2. The results shown in Fig. 4
indicate that the Tager 104 proteome is most closely
related to Newman, a strain isolated in 1952 from a
human patient and which has been well characterized
for its coagulase activity. Similarity in these genomes
supports the previously observed similarity in endocar-
ditis models [30]. Following this strain, Tager 104
was > 84 % similar to the nosocomial MRSA strain
04–02981, community-acquired MRSA strain SA268,
and the human pleural isolate DSM 20231. The great-
est proteomic differences were seen for strain ST398,
a typically ovine-associated strain isolated from a human
case of endocarditis, which was also the second-largest
proteomic divergence observed [33].
Tager 104 is an ancestor to clinical isolates
To determine the lineage of S. aureus reference strains
in relation to Tager 104, genomes were submitted to
Mauve alignment and conserved segments were stripped
and concatenated for each genome for phylogenetic ana-
lysis by RAxML. This alignment and phylogeny used
only core genomic regions present in all 75 S. aureus
strains available as of Oct. 1st 2015.
The resulting tree (Fig. 5 and Additional file 2: Figure S1)
shows Tager 104 to be the earliest branching member of a
Method: Celera Assembler + PBJelly
Number of contigs: 36
N50 Value: 131,143
Method: HGAP (PacBio SMRT Analysis Suite)
Method: SSPACE
Method: SPAdes
Number of contigs: 12
N50 Value: 289,232
Number of contigs: 8
N50 Value: 1,028,373
Number of contigs: 1
N50 Value: 2,820,837
Inputs: Nextera Paired-end 2 x 150
Scaffolding







Number of contigs: 5
N50 Value: 2,807,408
Inputs: PacBio RS 90-minute 
Inputs: Lucigen NxSeq (25 kbp)




Fig. 2 Construction of the Tager 104 Genome. a The Tager 104 genome was constructed using indicated methods, with each step incorporating
new genomic data (Inputs). First, Tager 104 paired-end reads from Illumina MiSeq sequencing were submitted to CLC Bio (Contigging). Resulting
contigs were scaffolded using reads from PacBio RS sequencing (Scaffolding). Due to the inability to further close scaffolds, PacBio RS data alone
was instead contigged using HGAP assembly (Contigging 2). The eight remaining contigs were then closed using Lucigen NxSeq mate-pair libraries
with the SSPACE algorithm. Single-headed arrows represent events where resulting data from the previous step was submitted to algorithms in the
subsequent step (Method). Steps in which results were interchangeable are indicated by two-headed arrows. The assembly is described in more detail
in “Methods.” b In order to confirm the completed genome, Lucigen NxSeq libraries were submitted with separate 2 × 250 paired-end reads in an
independent SPAdes construction devoid of previous read data from panel A. Results were identical to the finished genome
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clade containing strain 6850, M013, SA40, SA268,
SA957, ED133, and RF122. Strain 6850 was isolated
from a skin abscess at the University of Wisconsin in
1987, and was shown to progress from the abscess to
complications such as systemic abscesses and septic
arthritis [34]. This supports Tager 104 as a reference se-
quence for systemically-penetrating bacteria. As a posi-
tive control, 2 separate genome dataset corresponding
to COL and NRS100 were also used and there is indica-
tion that these strains are the same or closely related.
The results of our analysis are consistent with this
hypothesis.
Tager 104 contains a limited set of MGE-encoded
virulence factors targeted at host immunity
As Tager 104 was able to survive in septic murine
models, and due to its phylogenetic placement as an
ancestral S. aureus lineage, we investigated the genomic
content of MGE-encoded virulence factors that have
been previously identified and characterized [3]. The re-
sults demonstrate a limited set of encoded factors in the
Tager 104 genome that are predicted to be necessary for
bacterial survival during bacteremia (Fig. 6a). In
addition, BRIG analysis revealed similar genomic regions
between strains of the Tager clade (Fig. 6b).
Tager 104 is predicted to encode a νSaα-encoded
Staphylococcal super-antigen-like SSL, as well as νSaβ-
encoded leukotoxin D and E (lukD and lukE, respectively).
These factors are known to inhibit elements of innate im-
munity [35]. The νSaβ-island was also shown to contain
the hyaluronate lyase gene (hysA), which degrades hyalur-
onic acid found in host extracellular matrix.
The Tager 104 genome also indicates early exposure to
phage-carried virulence factors. Tager 104 contained the
Fig. 3 Graphical Depiction of Tager 104 Assembly. The Tager 104 genome was scaffolded using three separate technologies: contigs from MiSeq
reactions (red tiling), PacBio RS reads (yellow histogram), and scaffolds produced from the hybrid assembly of both (blue tiling). However, assembly
of the Tager 104 genome using these technologies were found insufficient alone, due to the presence of repeat regions. More specifically, long
repeats (>500 bp) create errors in de Bruijn graph untangling (gray tiling). In addition, the exact placement of short repeats, such as interspersed
nuclear elements (light blue tiling), RNA sequences (light red tiling) and simple repeats (light green tiling) create errors in construction. Areas rich in
repeats and low in sequencing coverage (Regions 1 and 2) reveal difficulties in genomic construction. These difficulties were overcome by providing
the construction algorithms with 20 kbp mate-pair information, provided by Lucigen NxSeq libraries
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Staphylococcal inhibitor of complement (scn), which
targets innate immunity by inhibiting phagocytosis by
neutrophils. Tager 104 was shown to contain the hlb-
interrupting phage described in the genomes of modern
clinical strains, such as N315, Mu50, MW2, NCTC8325,
MSSA476, MRSA252, USA300, JH1, JH9, and Newman
[7], and was defined here as φTGR1. Interestingly, Tager
104 also contains the PVL cassette (lukF-PV and lukS-
PV), a phage-transferred pore-forming leukocyte toxin
linked to necrotic infections. Tager 104 only contains
one enterotoxin, determined by BLAST analysis as an
exact match to the phage-transferred enterotoxin P [3].
PVL-positive S. aureus strains are certainly in the minor-
ity of the totality of S. aureus genomes sequenced to
Fig. 4 Proteomic Analysis of S. aureus Genomes. One S. aureus reference sequence GenBank files from each ST group of the completed genomes
as of Oct. 2015 were downloaded from the NCBI server and genes were called using the prodigalrunner algorithm on a CMG-Biotools system.
The names of the strains are listed with corresponding ST numbers below. Most relevant here, the comparisons to our Tager 104 genome are
shown in bold with the highest protein similarity (blue) and lowest similarity also shown. Percent paralogs within a given genome are shown at
the base of the blast matrix and correspond to the red heat map
Fig. 5 Whole-Genome Phylogenetic Analysis of S. aureus Reference Strains. Proximal branches nearest Tager 104 are shown for the phylogenetic
analysis of all S. aureus reference strains whose genome were available by Oct. 2015 (a) or isolates from the United States (b) based on Mauve
alignment and RAxML analysis. For a complete tree of all strains, please refer to Additional file 2: Figure S1. Bootstrap values represent the result of
100 trials
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Fig. 6 (See legend on next page.)
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date, but some notable strains include ST1 strains
(MW2 and USA400), ST8 strains (NCTC 8325, TW20,
USA300, and USA500), and ST239 (TW20).
In addition, Tager 104 was determined to contain one
unknown prophage and four unknown genomic islands,
indicated as φTGR2 and TGR1 through TGR4, respect-
ively. The contents of these islands were limited to
hypothetical and/or phage proteins (Additional file 3:
Table S2).
Tager 104 shows intermediate clinical adaptations
One group of pathogenicity islands that are non-phage
and non-SCC genomic islands are termed νSa islands,
and typically contain a combination of virulence factors
and either an intact or remnant recombinase [7]. Two
such islands, termed νSAα and νSAβ, were previously
found to be allelic, and are therefore typed and used in
conjunction with sequence type analysis for determination
of strain radiation. Comparison between the profiles of
the νSAβ genomic island for one community-acquired
MRSA (CA-MRSA) strain (COL), three hospital-acquired
MRSA (HA-MRSA) strains (MRSA252, Mu3, JH1), and
two ruminant host MSSA strains (S0385, RF122), as well
as Tager 104 demonstrated that S. aureus Tager 104 has
lost the majority of the bsa locus, with the exception of
bsaG (Fig. 7). However, S. aureus Tager 104 has not ac-
quired enterotoxin genes seen in other strains adapted for
the hospital setting (HA-MRSA). The loss of this bsa
locus, coupled with the gain of enterotoxins, has been
previously hypothesized to indicate a shift from the en-
vironmental niche to one of hospital acquisition [36].
Therefore, S. aureus Tager 104 may represent an inter-
mediate strain for the selection of this νSAβ profile in
the hospital setting.
S. aureus Tager 104 antibiotic resistance profile
To determine the potential of Tager 104 for the future
study of acquired antibiotic resistance, known MGE-
transferred resistance cassettes [3] were searched against
the completed genome using BLAST. No resistance
elements were detected (data not shown).
Minimum inhibitory concentrations (MIC) for S. aur-
eus Tager 104 were determined by challenging with E-
test strips for linezolid, vancomycin, erythromycin,
and oxacillin. MICs for antibiotics were determined by
E-test strip analysis and S. aureus Tager 104 demon-
strated resistance to LZ at 1 μg/mL, VA at 2–3 μg/mL,
ER at 0.064 μg/mL, and OX at 0.019 μg/mL (Fig. 8).
The vancomycin-intermediate susceptibility phenotype
of S. aureus Tager 104 was confirmed by a solution-
based test in a 96-well format; results confirm the
MIC to be about 3 μg/mL. S. aureus Tager 104 col-
onies on brain-heart agar plates are well-formed with
the absence of satellite projections that would denote
the presence of small colony variants and an overall
white color, which is unlike other vancomycin-
intermediate strains described previously [37].
Discussion
S. aureus infections range in presentation from localized
skin infections to more life-threatening osteomyelitis,
endocarditis, and sepsis. With the advent of next-
generation sequencing, analysis is now possible for indi-
vidual genomes across the spectrum of infections. These
data revealed that certain S. aureus strains exhibit con-
siderable changes in their gene make-up, thus reflecting
selective pressure to infect a certain host preferentially
[38]. The acquisition of MGE and smaller changes in
genes known as nucleotide polymorphisms together con-
fer the apparent selective advantages needed for these
strains to survive in a given host. The capacity for lateral
gene transfer in S. aureus strains fuels this potential for
rapid adaptation. For example, S. aureus Newman, iso-
lated in 1952, has been shown to contain four prophages
(φNM1–φNM4) and one additional νSa island, νSa4 [7].
The lack of these prophages was associated with de-
creased abscess formation in organs. However, a strain
such as MW2 lack these prophages, but was isolated
from a patient with abscesses of the brain, heart, liver,
and kidneys, leading to death [4, 39]. Therefore, the re-
quired machinery for a particular infection is highly
model-specific, and we suggest that reference strains
should be limited in scope to those which suffice for a
particular infection model.
Our previous results [30, 31, 40] suggested that S. aur-
eus Tager 104 is a potent strain for the formation of bac-
terial endocarditis, a serious complication of bacteremia.
This may not be surprising considering Tager 104 was
originally isolated and maintained for decades, due in no
small part for its potent ability to form stable clots in
(See figure on previous page.)
Fig. 6 Mobile Genetic Element-Encoded Virulence in S. aureus Tager 104. a Mobile genetic element (MGE)-encoded genes relevant for virulence
in S. aureus were selected based on prior knowledge of S. aureus genomics. Those elements detected by BLAST analysis in the Tager 104 genome
are indicated by locus (red bands) as well as gene name (red labels), and the genomic island responsible for carrying these elements are grouped
(black bar) and indicated beside the gene name (blue label). In addition, islands were detected using the IslandViewer 3 software, and are indicated by
locus (blue bands) and given identifiers (blue label) based on gene identities and BLAST result. b Blast ring analysis of loci from strains in the Tager 104
clade. Tager 104 GC content and GC skew are represented on the innermost ring, with percent identity reported for genomes in the Tager 104 clade
reported on the outermost rings as indicated
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human, rabbit, and sheep blood [41]. This clotting
phenotype has been attributed to the coordinated effort of
two non-proteolytic activators of prothrombin, namely
staphylocoagulase [16] and von Willebrand factor binding
protein [42, 43]. Both of these factors activate prothrom-
bin by forming a reversible complex that cleaves their
substrate fibrinogen to provide the fibrin barrier, similar
to those seen here in the focal abscesses in multiple or-
gans, including the kidney and spleen, that were formed
by simple induction of the infection by diffuse bacteremia
(Fig. 1). Because of these observations, and the early date
of its isolation, we sought to outline Tager 104 as a refer-
ence strain for the systemic infection niche. We therefore
determined the phylogenetic relationship of Tager 104 for
future evolutionary and correlation studies compared to
other S. aureus strains.
Our goal in genome sequencing was to find the sim-
plest and most inexpensive combination of technologies
to complete the Tager 104 genome so that it may be
used as a reference for future S. aureus genomic com-
parisons. We began with Illumina MiSeq 2 × 150 paired-
end libraries, constructed using a Nextera kit. To close
the genome, literature suggested that the use of PacBio
RS technology would enable bridging across complex re-
gions using longer reads [44]. PacBio reads were cor-
rected using Illumina MiSeq paired-end reads, and
scaffolded to create the final genomic construction. The
result from this “hybrid assembly” was twelve scaffolds,
which have been previously described [19]. However, no
combination of algorithms or manual assembly were
able to close the genome. New advancements in PacBio
construction, ushered by the release of the newer HGAP
assembly algorithm, led us instead to reconstruct the
genome using raw PacBio data alone, producing 8 scaf-
folds of varied sizes, which similarly did not result in a
complete genome and bridging these contigs manually
proved problematic. We therefore decided to approach
the closing of the genome using greater distances
between the paired reads to provide additional informa-
tion to the construction algorithms. Two Lucigen 20 kb
mate-pair libraries were sufficient to close the Tager 104
genome from this HGAP-assembled data. Furthermore,
Illumina 2 × 250 paired-end libraries were constructed,
sequenced, and assembled de novo. Upon addition of the
Lucigen mate-pair libraries, the final genome was pro-
duced. Therefore, the aforementioned Lucigen mate-pair
Fig. 7 Tager 104 νSaβ Genomic Island Shows Intermediate Clinical Adaptation. Representatives from each subtype of the νSaβ locus were selected and
compared using the RAST server. Current strains of community acquired MRSA (CA-MRSA) contain the bsa locus (red arrows), which encodes a bacterial
antibiotic. In contrast, hospital-acquired MRSA (HA-MRSA) have lost the bsa locus and instead gained enterotoxins (yellow arrows), an adaptation which
has been previously associated with a selection for hospital settings. Results indicate Tager 104 has lost the bsa locus, but lacks the enterotoxin cluster
(yellow) that has also been associated with this shift. In contrast, ruminant-host MSSA shows a wide range of these genotypes
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library could be used to independently assemble the
Tager 104 MiSeq 2 × 250 bp reads. This provides a
proof of principle to guide a streamlined protocol for
assembly.
To interpret this S. aureus Tager 104 genomic dataset in
the auspices of the systemic niche, it will need to have the
following characteristics: (1) be a clinical sample, (2) be an
early branching member of the S. aureus phylogenetic
tree, and (3) be limited in MGE content to those which
are necessary for systemic survival (i.e., immune system
evasion). Based on the results of these analyses, Tager 104
has been found to have all of these characteristics. Tager
104 has been maintained from primary freezer stocks
since its isolation in the late 1940’s. Tager 104 shows an-
cestral phylogeny similar to other methicillin-resistant and
methicillin-susceptible strains that have been character-
ized in the literature [45]. This clade is made up of two
systemic isolates (6850 and SA957), one wound isolate
(M013), one nasopharygenal isolate (SA40), and two ru-
minant isolates (ED133 and RF122). Interestingly, SA957
occurs later in the lineage than SA40 and has been associ-
ated with more severe septic infections and higher mortal-
ity rates [46]. This differentiation was hypothesized to be
due to the loss of the β-hemolysin-interrupting phage.
Tager 104 shows a limited set of MGE content primar-
ily focused on the evasion of host innate immunity.
Tager 104 was shown to contain the hlb-interrupting
phage described above, labeled as φTGR1, as well as two
additional phages. One of these phages contained PVL,
indicating the earliest acquisition of this factor in the
literature. The other phage was shown to carry no
additional genes aside from those necessary for phage
construction and replication (Additional file 3: Table S2).
For comparison, prophage φTGR1 and φTGR2 were
compared proteomically using BLAST matrix analysis
with complete phage genomes downloaded from the
GenBank server, and showed low homology to three
phage genomes (Additional file 4: Figure S2). In addition,
Tager 104 was shown to contain the νSaα and νSaβ
islands, found in all S. aureus genomes [7]. Although
Tager 104 was also detected to contain four additional
potential genomic islands, their gene content consisted
solely of hypothetical proteins. Therefore, the virulence-
associated genomic island composition of Tager 104 is
limited to those which are found in all genomes (νSaα,
νSaβ), the hlb-interrupting phage found in most all human
or animal pathogenic S. aureus (φTGR1), and the PVL-
carrying phage strains.
The S. aureus Tager 104 genome also indicates that
this strain pre-dates the acquisition of the SCCmec cas-
sette and may serve to bridge certain clinical MRSA and
MSSA strains (Fig. 5 and Additional file 2: Figure S1).
Supportive to this hypothesis is the recent observation
of an ST49-t208 strain that has become methicillin-
resistant [47], potentially through the acquisition of the
mecALGA251 cassette [48]. These results indicate that
Tager 104 represents an intermediate departure in the
evolution of multi-drug resistant S. aureus. Antibiotic
susceptibility of S. aureus Tager 104 presented here
using clinically approved E-test analysis corroborates
genomic data (Fig. 8) and indicates that Tager 104 dis-
plays a borderline vancomycin intermediate S. aureus
phenotype (Fig. 8b & e). In fact, current vancomycin
guidelines would prohibit use of vancomycin in patients
Fig. 8 S. aureus Tager 104 Susceptibility to Antibiotic Therapy
Demonstrates Predation of Resistance Development. a–d Antibiotic
susceptibility testing on sheep blood agar (SBA) plates demonstrated
S. aureus Tager 104 is susceptible to linezolid (a), vancomycin (b),
erythromycin (c), and oxacillin (d) when challenged with E-test strips.
Minimum Inhibitory concentrations shown are: linezolid, 1 μg/mL;
vancomycin, 2–3 μg/mL; erythromycin, 0.064 μg/mL; and oxacillin,
0.019 μg/mL. e The effects of vancomycin concentrations on
Tager 104 growth were confirmed in solution in 96-well plates
and indicate a vancomycin intermediate susceptibility phenotype.
This experiment is a combination of 8 replicates and was performed as
described in "Methods"
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where the isolated strain MIC for vancomycin is equal
to or over 2 μg/mL making any potential enhancement
to vancomycin resistance or small colony variant forma-
tion by Tager 104 could be of significant importance to
the understanding of acquired S. aureus resistance.
Interestingly, Tager 104 also shows an intermediate
adaptation to the nosocomial environment. Tager 104
proteome analysis (Fig. 4) showed an equivalent homology
to both community acquired strain SA268 (84.6 %) and
nosocomial strain 04–02981 (84.3 %). Therefore, we inves-
tigated further the νSaβ genomic island, which has been
previously implicated in the shift to hospital settings. Our
analysis (Fig. 7) revealed that Tager 104 has lost the genes
necessary for competition for resources in the environ-
ment, but had yet to gain those necessary for spread in a
clinical setting at its time of isolation.
It has been recently suggested that the acquisition of
these MGEs may be driven by “glycocodes” encoded by
the teichoic acid structure of S. aureus, as these struc-
tures are recognized by bacteriophages during transduc-
tion events [49]. With this in mind, we investigated the
locus of teichoic acid biosynthesis in S. aureus Tager
104, COL (as a representative of early MRSA strains)
and JH1 (as a representative of early VRSA strains) with
the hypothesis that homology in these strains indicate a
potential phage-mediated acquisition of MGEs. The
results indicate that the genomic makeup of this biosyn-
thesis cluster is identical in these three strains (Additional
file 5: Figure S3). Therefore, a strain ancestral to Tager
104 acquired resistance elements from bacteriophages,
leading to the evolution of more recent clinical MRSA
and VRSA strains, in agreement with this phylogenetic
analysis (Fig. 5 and Additional file 2: Figure S1). As ex-
pected, the PS187 genome described previously showed a
very distinct profile, furthering the previous conclusion
that this strain is distantly related to other known S. aur-
eus lineages. Further analysis will be required to investi-
gate the origin of resistance transfer into Tager 104 and its
contribution to S. aureus virulence.
Conclusions
Identification of a suitable reference strain for the study
of S. aureus pathogenicity is a crucial issue that can give
both context and scope to certain single nucleotide poly-
morphisms present in modern S. aureus isolates. Further-
more, the study of the transfer of MGEs between closely
related strains may ultimately provide insight into the
underlying adaptive pressures that allow these strains to
cause disease in a given host. In this article, we have
demonstrated that Tager 104 displays a virulent
phenotype. Phylogenetic analysis, as well as a set of MGE-
encoded factors limited to that which is necessary for
systemic survival, suggest that Tager 104 can be used as a
reference strain for future studies of S. aureus systemic
virulence. We have also placed the Tager 104 genome in
context with all 75 completed S. aureus genomes and
shown similarities between Tager 104 genomic islands and
other human S. aureus pathogens. Moreover, we have
established a methodology for the closing of complex
genomic repeat regions that may accelerate closure of
other genomes in the future, thereby providing an impact
to researchers outside the S. aureus field. Given the early
original isolation of the S. aureus Tager 104, the complete
characterization presented here should provide new
insights into the evolution of this dangerous pathogen.
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